Revolution Medicines

Revolution Medicines is a clinical-stage biotechnology company dedicated to discovering and developing innovative targeted therapies for patients with RAS-addicted cancers. The company's pipeline includes investigational medicines built on its Tri-Complex platform, which targets RAS(ON) proteins. As a publicly traded biotech firm, it operates with a global reach, with its headquarters in Redwood City, California, and a growing presence in Europe.

In Spain, Revolution Medicines is establishing a commercial and medical affairs footprint, with open roles in marketing, field medical advising, regulatory affairs, corporate affairs, and market access. These positions indicate a focus on preparing for potential product launches and building local capabilities. The company's work culture emphasizes scientific innovation and patient-centricity, making it an attractive employer for international professionals seeking to contribute to cutting-edge oncology research and development.